⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL2125116 | 0.96 | — | — | |
| Acetonitrile SCHEMBL3755773 | 0.96 | — | — | |
| Acetonitrile SCHEMBL1832586 | 0.96 | — | — | |
| Acetonitrile SCHEMBL28350050 | 0.96 | APLNR (0.32) | — | |
| Acetonitrile SCHEMBL29125464 | 0.96 | APLNR (0.32) | — | |
| Acetonitrile SCHEMBL28017081 | 0.96 | — | — | |
| Acetonitrile SCHEMBL19211025 | 0.96 | APLNR (0.32) | — | |
| Acetonitrile SCHEMBL583918 | 0.96 | — | — | |
| Acetonitrile SCHEMBL9936942 | 0.93 | APLNR (0.33) | — | |
| Acetonitrile SCHEMBL15092908 | 0.93 | APLNR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113092598-B | Method for detecting miglitol intermediate | 鲁南制药集团股份有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-111413451-B | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | 京博农化科技有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-107782821-B | Analysis method of neuromuscular blocking agent | 四川科瑞德制药股份有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-113092598-A | Detection method of miglitol intermediate | 鲁南制药集团股份有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-111965285-A | Method for detecting content of tulathromycin | 天津市中升挑战生物科技有限公司 | 2020-11-20 | — | — | CN | claimed |
| CN-110954630-B | Method for detecting aspirin content in blood plasma and pretreatment kit | 山东英盛生物技术有限公司 | 2020-11-13 | — | — | CN | claimed |
| CN-111413451-A | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | 京博农化科技有限公司 | 2020-07-14 | — | — | CN | claimed |
| CN-110954630-A | Method for detecting aspirin content in blood plasma and pretreatment kit | 山东英盛生物技术有限公司 | 2020-04-03 | — | — | CN | claimed |
| CN-113092598-B | Method for detecting miglitol intermediate | 鲁南制药集团股份有限公司 | 2023-06-20 | — | — | CN | disclosed |
| CN-113092598-B | Method for detecting miglitol intermediate | 鲁南制药集团股份有限公司 | 2023-06-20 | — | — | CN | disclosed |
| US-11524012-B1 | Quinolone analogs and their salts, compositions, and method for their use | SENHWA BIOSCIENCES, INC. (TW) | 2022-12-13 | — | — | US | disclosed |
| CN-111413451-B | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | 京博农化科技有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-109358140-B | Rifaximin raw material and detection method of preparation components thereof | 上海市食品药品检验研究院 | 2021-07-30 | — | — | CN | disclosed |
| CN-113092598-A | Detection method of miglitol intermediate | 鲁南制药集团股份有限公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-111965285-A | Method for detecting content of tulathromycin | 天津市中升挑战生物科技有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-111413451-A | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | 京博农化科技有限公司 | 2020-07-14 | — | — | CN | disclosed |
| WO-2019168688-A9 | QUINOLONE ANALOGS AND THEIR SALTS, COMPOSITIONS, AND METHOD FOR THEIR USE | SENHWA BIOSCIENCES, INC. (TW) | 2019-11-14 | — | — | WO | disclosed |
| CN-110243956-A | A kind of food lipids extraction and the method for detecting food lipid | 北京三元食品股份有限公司 | 2019-09-17 | — | — | CN | disclosed |
| CN-109358140-A | Rifaximin raw material and detection method of preparation components thereof | 上海市食品药品检验所 | 2019-02-19 | — | — | CN | disclosed |
| EP-2394998-A1 | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors | Almirall, S.A. (ES) | 2011-12-14 | — | — | EP | disclosed |